SIMONE, Isabella Laura
 Distribuzione geografica
Continente #
NA - Nord America 10.439
EU - Europa 1.984
AS - Asia 1.714
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
SA - Sud America 6
Totale 14.156
Nazione #
US - Stati Uniti d'America 10.422
CN - Cina 792
SE - Svezia 515
HK - Hong Kong 479
IT - Italia 352
SG - Singapore 338
UA - Ucraina 319
DE - Germania 290
FI - Finlandia 207
GB - Regno Unito 129
FR - Francia 64
VN - Vietnam 37
IN - India 34
BE - Belgio 33
IE - Irlanda 27
CA - Canada 15
AE - Emirati Arabi Uniti 12
NL - Olanda 9
EU - Europa 7
LT - Lituania 7
PL - Polonia 7
IR - Iran 6
AU - Australia 5
BR - Brasile 5
KR - Corea 4
RO - Romania 4
BG - Bulgaria 3
JP - Giappone 3
PT - Portogallo 3
RU - Federazione Russa 3
CZ - Repubblica Ceca 2
ES - Italia 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
TR - Turchia 2
AT - Austria 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
LV - Lettonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 14.156
Città #
Fairfield 1.474
Woodbridge 1.143
Chandler 892
Houston 775
Jacksonville 760
Ashburn 719
Seattle 613
Wilmington 541
Cambridge 512
Ann Arbor 478
Nyköping 369
Singapore 247
Lawrence 220
Roxbury 220
Nanjing 176
New York 158
Boardman 148
Des Moines 147
Beijing 145
Princeton 93
Bari 85
San Diego 71
Nanchang 62
Inglewood 60
Hebei 54
Dearborn 50
Jiaxing 49
Shenyang 46
Santa Clara 42
Brooklyn 40
Falls Church 38
Dong Ket 36
Tianjin 36
Brussels 33
Marseille 30
Los Angeles 29
Paris 29
Dublin 27
London 27
Norwalk 27
Changsha 25
Redwood City 24
Guangzhou 21
Pune 19
Munich 16
Helsinki 15
Taranto 15
Jinan 12
San Mateo 12
Washington 12
Indiana 11
Leawood 11
Shanghai 11
Auburn Hills 10
Monmouth Junction 10
Conversano 9
Kunming 9
Rome 9
Turin 9
Zhengzhou 9
Hefei 8
Milan 8
Shenzhen 8
Wuhan 8
Augusta 7
Hong Kong 7
Toronto 7
Venezia 7
Ardabil 6
Hangzhou 6
Hounslow 6
Kilburn 6
Ningbo 6
San Francisco 6
Wuxi 6
Edinburgh 5
Menlo Park 5
Mottola 5
Padova 5
Palermo 5
St Louis 5
Frankfurt am Main 4
Mapello 4
Prescot 4
Ruvo Di Puglia 4
Yiwu 4
Canberra 3
Florence 3
Haikou 3
Hyderabad 3
Mumbai 3
Ottawa 3
Romola 3
Simi Valley 3
Sofia 3
Taizhou 3
Tappahannock 3
Tokyo 3
Warsaw 3
Amantea 2
Totale 11.163
Nome #
Adherence to riluzole in patients with amyotrophic lateral sclerosis: An observational study 602
Corrigendum: Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 138
Assisting persons with advanced amyotrophic lateral sclerosis in their leisure engagement and communication needs with a basic technology-aided program 129
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis 123
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study 119
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 118
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 116
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 113
Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 113
Double-Blind Placebo-Controlled Trial on the Use of Acetyl-L-Carnitine for the Treatment of Amyotrophic Lateral Sclerosis (P04.151) 109
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 109
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 107
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 107
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia 107
null 101
null 100
Convexal subarachnoid hemorrhage and acute ischemic stroke: a border zone matter? 100
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis 98
Intrathecal immune response in human immunodeficiency virus infection 97
MR evaluation of encephalic leukoaraiosis in sudden sensorineural hearing loss (SSNHL) patients 97
A Novel CSF1R Mutation in a Patient with Clinical and Neuroradiological Features of Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids 96
null 95
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. 94
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 94
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 93
Long term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience 91
null 88
Hirayama disease: the importance of an early diagnosis 88
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 88
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy 86
The role of imaging in Hirayama disease 86
null 85
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 85
null 84
null 83
HFE p.H63D polymorphism does not influence ALS phenotype and survival 83
Verbal Learning Abilities in ALS Patients (P01.109) 83
Multiparametric unconventional MRI study in early stage of ALS disease 83
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study 82
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 81
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 80
N-Acetyl-Aspartate (NAA) and Neurofilament-Light Chain (NF-L) in biological fluids as markers of neurodegeneration in ALS 78
null 78
null 78
null 78
null 78
1H-MR Spectroscopy profiles in normal appearing white matter(NAWM) of clinically isolated sindromes suggestive of multiple sclerosis(CIS) 77
null 77
null 77
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial) 77
High resolution proton MR-spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques 76
null 75
null 75
null 75
null 75
null 74
null 74
null 73
null 73
1H-MRSA comparison of normal appearing white matter in different clinical MS subgroups 73
null 72
null 72
null 72
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled,multicentre clinical trial for colchicine in ALS (Co-ALS) 72
null 71
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 71
null 71
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 71
null 71
null 71
null 71
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG. 71
null 70
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 70
null 69
null 68
null 68
null 68
null 68
Life-threatening ADEM in an immunocompetent pregnant woman with concomitant asymptomatic Cytomegalovirus infection 68
null 67
null 67
null 66
null 66
null 65
null 65
null 65
Intra blood-barrier (BBB) immune rersponse in HIV-infected patients 64
null 64
null 64
null 64
null 64
null 64
Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels in ALS Patients 63
null 63
null 62
null 62
Elevated plasma homocystein levels in patients with Amyotrophic lteral sclerosis 61
null 61
null 61
Totale 8.655
Categoria #
all - tutte 59.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.078


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.666 0 0 0 0 420 230 378 322 439 199 589 89
2020/20212.677 240 180 284 246 230 220 247 159 225 306 187 153
2021/20221.856 53 75 16 37 80 170 45 71 96 108 260 845
2022/20232.235 362 220 157 210 286 250 32 247 385 14 40 32
2023/2024789 55 148 49 38 51 227 21 34 18 20 5 123
2024/2025685 107 64 314 119 81 0 0 0 0 0 0 0
Totale 14.930